Related Experiment Video
Updated: May 8, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Engineered single chain variable fragments (scFvs) with improved pH-dependent kinetics for use in continuous
Ellie D Wilson1, David Probst1, Mai Hamasaki1,2
1Lampe Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill, North Carolina State University Chapel Hill NC 27599 USA ksode@email.unc.edu.
Abstract:
One challenge in the continuous monitoring of insulin lies with the unavailability of a high-affinity biological recognition element (BRE) with kinetic parameters sufficient to track fluctuating concentrations of insulin in vivo. An approach to overcome this limitation is to engineer a high-affinity BRE to selectively modulate its binding kinetics in response to an external signal. Herein, we design and evaluate changes in the pH-dependent binding kinetics of an anti-insulin single chain variable fragment (scFv) we previously employed in a point-of-care insulin sensor. We predicted the scFv structure in complex with human insulin and selected scFv residues directly involved in insulin binding for histidine substitution. We identify one mutation, T32H, that improves the pH-sensitivity of the wild-type (WT); the K D of the T32H mutant is calculated to be 145.5 ± 83.1 nM at pH 7.4 and 17.4 ± 5.1 nM at pH 6.0 - an average of an 8.4× difference between the two conditions and a 3.8× increase in pH-sensitivity from the WT. We design a bio-layer interferometry (BLI) assay to interrogate the improved pH-sensitivity of the T32H mutant in tracking fluctuating insulin concentrations in dynamic pH conditions and find that improved pH-sensitivity can be leveraged to improve biosensor regeneration. These results suggest the potential for pH-sensitive antibodies to improve the development of in vivo continuous monitoring systems.
More Related Videos
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022